These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32241521)

  • 1. [Study of practices: What do general practitioners first propose when faced with asymptomatic lower extremity peripheral artery disease?].
    Rochoy M; Baran J; Doublali A; Berkhout C; Favre J; Descamps A
    Ann Cardiol Angeiol (Paris); 2020 Apr; 69(2):55-59. PubMed ID: 32241521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the ankle-brachial index in the detection of peripheral arterial disease of the lower extremities in general medicine].
    Rochoy M; Doublali A; Berkhout C
    Ann Cardiol Angeiol (Paris); 2021 Apr; 70(2):75-80. PubMed ID: 33642048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
    Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.
    Al-Omran M
    Vasc Health Risk Manag; 2012; 8():349-55. PubMed ID: 22701328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ankle brachial index: motivations, training, and practices among 165 general practitioners in Île-de-France].
    Meyer D; Bureau JM; Vu Tri D
    J Mal Vasc; 2014 Feb; 39(1):18-25. PubMed ID: 24332303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease.
    Steenhof N; Le Piane F; Leblanc K; Eisenberg NR; Kwan Y; Malmberg C; Papadopoulos A; Roche-Nagle G
    Vasc Health Risk Manag; 2014; 10():333-40. PubMed ID: 24940068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
    J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Adherence to Peripheral Arterial Disease Guidelines and Suboptimal Ankle Brachial Index Reliability in Dutch Primary Care.
    Hageman D; Pesser N; Gommans LNM; Willigendael EM; van Sambeek MRHM; Huijbers E; Snoeijen A; Scheltinga MRM; Teijink JAW
    Eur J Vasc Endovasc Surg; 2018 Jun; 55(6):867-873. PubMed ID: 29576335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Guideline-Recommended Therapy-Including Supervised Exercise Therapy Referral-Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry.
    Saxon JT; Safley DM; Mena-Hurtado C; Heyligers J; Fitridge R; Shishehbor M; Spertus JA; Gosch K; Patel MR; Smolderen KG
    J Am Heart Assoc; 2020 Feb; 9(3):e012541. PubMed ID: 31973609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions.
    Kim TI; Chen JF; Orion KC
    Vasc Med; 2019 Dec; 24(6):528-535. PubMed ID: 31686603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Centre Study on Cardiovascular Risk Management on Patients Undergoing AAA Surveillance.
    Saratzis A; Dattani N; Brown A; Shalhoub J; Bosanquet D; Sidloff D; Stather P;
    Eur J Vasc Endovasc Surg; 2017 Jul; 54(1):116-122. PubMed ID: 28554728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study of the medical management of patients with peripheral artery disease.
    Saratzis A; Jaspers NEM; Gwilym B; Thomas O; Tsui A; Lefroy R; Parks M; Htun V; Mera Z; Thatcher A; Bosanquet D; Forsythe R; Benson R; Dattani N; Dovell G; Lane T; Shalhoub J; Sidloff D; Visseren FLJ; Dorresteijn JAN; Richards T;
    Br J Surg; 2019 Aug; 106(9):1168-1177. PubMed ID: 31259387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.
    Al-Omran M
    Vasc Health Risk Manag; 2007; 3(6):1019-27. PubMed ID: 18200820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study.
    Blacher J; Cacoub P; Luizy F; Mourad JJ; Levesque H; Benelbaz J; Michon P; Herrmann MA; Priollet P
    J Vasc Surg; 2006 Aug; 44(2):314-8. PubMed ID: 16890860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.